The PASTEUR Act of 2026 aims to ensure the availability of innovative antimicrobial drugs by establishing a contract program with sponsors.
The PASTEUR Act of 2026 amends the Public Health Service Act to create a program for developing innovative antimicrobial drugs targeting serious infections. The Act authorizes the Secretary of Health and Human Services to enter into contracts with sponsors of eligible antimicrobials to ensure their availability. Eligible antimicrobials must treat pathogens deemed urgent or serious threats and address unmet medical needs.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.